Ledger.Open graph →
SEC Form D · Amendment · filed June 19, 2009

ALIOS BIOPHARMA INC

Offering
$11.0M
Sold
$11.0M
Exemption
—
Industry
Pharmaceuticals
Location
SOUTH SAN FRANCISCO, CA
Type
—

People & firms on this filing (10)

Kent Gossett · South San Francisco, CADirectorLawrence Blatt · South San Francisco, CAExec · DirectorLeonid Beigelman · South San Francisco, CAExecJack Nielsen · South San Francisco, CADirectorCampbell Murray · South San Francisco, CADirectorSimon Ridgway · Vancouver, British Columbia, CanadaExec · DirectorMario Szotlender · Vancouver, British Columbia, CanadaExecInvestment Manager Bny Mellon, N.A · Pittsburgh, PADirectorCharles A. Warden · Menlo Park, CADirectorDiane Dewbrey · Bellevue, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗